Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Oxford Nanopore Technologies Plc (ONT.LN)

Oxford Nanopore Technologies Plc (ONT.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oxford Nanopore Technologies Plc Edmund Halley Road Gosling Building, Oxford Science Park Oxford Oxfordshire OX4 4DQ GBR

https://www.nanoporetech.com P: 845-034-7900 F: 845-034-7901

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The company is predominantly involved in researching, developing, manufacturing, and commercializing a nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company's reportable segments are; Life Science Research Tools which generates key revenue, and COVID Testing.

Key Statistics

Overview:

Market Capitalization, $K 1,109,043
Shares Outstanding, K 966,908
% of Insider Shareholders 2.53%
% of Institutional Shareholders 17.94%

Financials:

Annual Sales, $ 183,191 K
Annual Net Income, $ -146,188 K

Growth:

1-Year Return 7.42%
3-Year Return -43.15%
5-Year Return 0.00%
5-Year Revenue Growth 28.61%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.15
Dividend Payout Ratio 0.00%

ONT.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -26.01%
Return-on-Assets % -20.55%
Profit Margin % -79.80%
Debt/Equity 0.07
Price/Sales 5.22
Price/Book 2.12
Book Value/Share 0.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar